Stay updated on AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial

Sign up to get notified when there's something new on the AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    New revision v3.5.4 appears in the Record History, replacing v3.5.3. This represents a subsequent update to the study record since the previous revision, rather than a change to specific trial details.
    Difference
    0.1%
    Check dated 2026-05-15T03:13:03.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The Record History shows a new revision, v3.5.3, replacing the previous v3.5.2, indicating an update to the page's release notes for this study record.
    Difference
    0.1%
    Check dated 2026-04-30T16:52:07.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Record history shows the addition of Revision v3.5.2 and removal of Revision v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:40:58.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    A new site revision entry (Revision: v3.5.0) was added and the previous entry (Revision: v3.4.3) was removed from the record history.
    Difference
    0.1%
    Check dated 2026-03-25T21:00:48.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    A new revision v3.4.3 is added and revision v3.4.2 is removed from the history.
    Difference
    0.1%
    Check dated 2026-03-11T16:12:53.000Z thumbnail image
  9. Check
    111 days ago
    Change Detected
    Summary
    Version 6 adds core study record sections—Study Design, Study Description, Sponsor/Collaborators, Study Status, and Study Identification (revision: v3.4.2). It also removes the previous government funding notice and the AnHeart Therapeutics reference.
    Difference
    3%
    Check dated 2026-02-11T02:54:05.000Z thumbnail image

Stay in the know with updates to AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AB-106 in Advanced NSCLC with ROS1 Fusion Gene Clinical Trial page.